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We examined the inhibitory eﬀect of polyphenol-rich aqueous extract from the bark of Acacia mearnsii (PrA)on itching associated
with atopic dermatitis (AD). HR-1 mice were fed a normal diet, special diet (AD group), or special diet containing 3% PrA (PrA
group) for 6 weeks. In the AD group, itching frequency and transepidermal water loss increased compared to the control group.
In the PrA group, an improvement in atopic dermatitis symptoms was observed. Ceramide expression in the skin decreased in
the AD group compared to the control group, but no decrease was observed in the PrA group. mRNA expression of ceramidase
decreased in the PrA group compared to the AD group. The results of this study have revealed that PrA inhibits itching in atopic
dermatitis by preventing the skin from drying. It is considered that the mechanism by which PrA prevents the skin from drying
involves the inhibition of increased ceramidase expression associated with atopic dermatitis.
1.Introduction
Acacia is an evergreen tree belonging to the genus Acacia in
the legume family, and it is widely distributed throughout
the Australian and African continents. The extract of Acacia
catechu duramen is called gambir, and it has long been
used as an astringent and antibacterial to treat stomatitis
and diarrhoea in Japan and China. In Europe, polyphenol-
rich aqueous extract from the bark of Acacia mearnsii De
Wild. (PrA), which is widely distributed throughout South
Africa, has been used to eliminate wine sediment. Australian
aborigines also eat the young leaves and beans of Acacia
mearnsii De Wild.
WehavealreadydemonstratedthatPrAexertsantiobesity
and antidiabetic actions by altering the expression of genes
associated with the inhibition of obesity and diabetes in
skeletal muscle, liver, and white adipose tissues [1]. We have
also shown that PrA inhibits lipase and glucosidase activities,
resulting in the inhibition of an increase in the plasma
triglyceride and glucose levels [2].
In recent years, it has been reported that polyphenols
exert various pharmacological actions, including antiobesity
actions[3,4],antidiabeticactions[5],andantiallergyactions
[6, 7]. PrA is rich in unique catechin-like ﬂavan-3-ols, such
as robinetinidol and ﬁsetinidol [8]. The catechins such as tea
polyphenol [9, 10] and apple polyphenol [11]a r ee ﬀective
in treating atopic dermatitis to some extent. Therefore, it
is considered that PrA may also possibly exhibit antiatopic
eﬀects. To induce atopic dermatitis-like symptoms in this
study, HR-1 hairless mice were given a special diet that does
not containmagnesium [12,13].Theinhibitory eﬀectofPrA
on itching associated with atopic dermatitis was examined
using these mice.
2.MaterialsandMethods
2.1.HotWaterExtractionfromAcaciaBark. PrA was donated
by Mimozax Co., Ltd. (Hiroshima, Japan) and prepared
according to the methods reported by Cutting [14]. Brieﬂy,
thepowderedbarkofSouthAfricanAcaciamearnsiiDeWild.
was pulverised and extracted for 30min in a 10-fold volume
of hot water (100◦C) and then dried using a spray drier. The
extract yield was approximately 35% (w/w).2 Evidence-Based Complementary and Alternative Medicine
The polyphenol content of the present product as meas-
ured by the Stiasny reaction was 79.0%. The average molec-
ular weight of PrA is 1,250 (300–3,000), and PrA contains
robinetinidol, ﬁsetinidol, syringic acid, gallocatechin, cate-
chin, robinetinidol-(4α,8)-gallocatechin, and so forth [8].
PrA does not contain magnesium.
2.2. Materials. Propidium iodide (PI) solution was pur-
chased from Wako Pure Chemicals (Osaka, Japan). Bovine
serum albumin (BSA), mouse anticeramide antibody, and
TRI reagent were purchased from Sigma-Aldrich Corp.
(St. Louis, MO, USA). Rabbit anti-rat AQP3 antibody was
purchased from Alomone Labs (Jerusalem, Israel). Alexa
Fluor 488 anti-rabbit IgG, Alexa Fluor 488 anti-mouse
IgM antibody, and primers were purchased from Invitrogen
Corp. (Tokyo, Japan). Anti-rabbit IgG-HRP antibody was
purchased from Santa Cruz Biotechnology Inc. (Santa Cruz,
CA, USA). An enhanced chemiluminescence system (ECL)
plus western blotting detection reagents were purchased
fromGEHealthcare(ChalfontSt.Giles,UK).Ahighcapacity
cDNA synthesis kit was purchased from Applied Biosystems
(Foster City, CA, USA). An iQ SYBR green supermix was
purchased from Bio-Rad Laboratories (Hercules, CA, USA).
All other reagents were of the highest commercially available
grade.
2.3. Animals and Treatments. HR-1 hairless mice (4 weeks
old) were purchased from Hoshino laboratory animals,
Corp. (Ibaraki, Japan). Mice were kept at room temperature
(24±1◦C) and 55±5% humidity with 12h of light (artiﬁcial
illumination:08:00–20:00).Thepresentstudywasconducted
in accordance with the Guiding Principles for the Care and
Use of Laboratory Animals, as adopted by the Committee on
Animal Research at Hoshi University.
Mice that had been acclimated for 1 week were divided
into four groups. Each group was provided with ad libitum
access to a normal diet (Table 1, Nosan Corp., Kanagawa,
Japan), commercial special diet (HR-AD diet, Table 1,N o s a n
Corp.), HR-AD diet containing 1.5%(w/w)PrA, or HR-AD
diet containing 3.0%(w/w)PrA for 6 weeks. After 6 weeks,
the skin was removed, frozen in liquid nitrogen, and stored
at −80◦C.
2.4.AnalysisofSpontaneousScratchingBehaviour[12,13]. At
4 and 6 weeks after the administration, we observed the itch-
ing behaviour in mice. The spontaneous itching behaviour
of mice was videotaped for 1h with a video camera. The
scratching,grooming,andlickingbehaviourwasobservedby
watching the videotape.
2.5. Measurement of Dermal Water Content and Transepi-
dermal Water Loss. At 6 weeks after the administration, the
dermal water content was measured using a Tewameter
(TM300, Courage & Khazaka, Cologne, Germany). The
transepidermal water loss was measured using a Corneome-
ter(CM825,Courage&Khazaka).Thesemeasurementswere
carried out at 23 ±1◦Ca n d6 0±10% humidity.
Table 1: Ingredients of normal and HR-AD diets for HR-1 hairless
mice.
Normal diet Special diet
General ingredients
Moisture 9.2% 1.6%
Crude protein 18.8% 21.6%
Crude fat 3.9% 0.1%
Crude ﬁbre 6.6% 4.4%
Crude ash 6.9% 5.6%
Minerals
Ca 1.0% 0.9%
P 0.8% 0.8%
Mg 0.3% 0.0%
K 1.0% 0.4%
Na 0.3% 0.2%
Fe 240mg/kg 277mg/kg
Mn 101mg/kg 80mg/kg
Zn 89mg/kg 123mg/kg
I 0.77mg/kg 0.22mg/kg
Co 0.08mg/kg 0.002mg/kg
Cu 14mg/kg 22mg/kg
Vitamins (1kg)
A 16150IU 32157IU
D3 3169IU 4799IU
E 45mg 160mg
K1 5 m g 5 m g
B1 11mg 13mg
B2 9mg 16mg
B6 19mg 53mg
B12 0.03mg 0.08mg
Biotin 0.3mg 0.8mg
Pantothenic acid 25mg 30mg
Choline 1820mg 868mg
Folic acid 2.6mg 0.1mg
Inositol 10mg unknown
Niacin 102mg 320mg
2.6. RNA Preparation from Tissue Samples. RNA was extract-
ed from about 20mg of frozen skin using the TRI reagents
RNA extraction was performed according to the protocol
for the TRI reagents. The resulting solution was diluted 50-
fold using Tris/EDTA buﬀer (TE buﬀer), and the purity and
concentration(μg/mL)ofRNAwerecalculatedbymeasuring
absorbances at 260 and 280nm using a U-2800 spectropho-
tometer (Hitachi High Technologies, Tokyo, Japan).
2.7. Real-Time RT-PCR. A high-capacity cDNA synthesis kit
was used to synthesise cDNA from 1μgo fR N A .T Eb u ﬀer
was used to dilute the cDNA 20-fold to prepare the cDNA TE
buﬀer solution. The expression of target genes was detected
by preparing the primers listed in Table 2 and by performing
real-time RT-PCR. To each well of a 96-well PCR plate, 25μL
of iQ SYBR green supermix, 3μL of forward primer of the
target gene (5pmol/μL), 3μL of reverse primer (5pmol/μL),Evidence-Based Complementary and Alternative Medicine 3
Table 2: Primer sequences of mouse mRNA.
Target Accession number Forward primer (5  to 3 ) Reverse primer (5  to 3 )
AQP3 NM 016689 CTCATGTTGTGCCAGAGTGTG CCATCAGCAAGCCTAGAAGTC
serine palmitoyl transferase NM 011479 CTGTGCTCACATATGTGGGCT CTTTCTGTTGCATGGTGGCAC
ceramidase NM 019734.2 GCAGAACACCGGCCAAG CAGTCAGCTTGTTGAGGACAG
GAPDH NM 008084 GGCAAATTCAACGGCACAGT AGATGGTGATGGGCTTCCC
4μL of cDNA TE buﬀer solution, and 15μL of RNase-free
water were added. The denaturation conditions were 95◦C
for 15s, the annealing conditions were 56◦C for 30s, and the
elongation conditions were 72◦C for 30s. The ﬂuorescence
intensity of the ampliﬁcation process was monitored using
the My iQ single colour real-time RT-PCR detection system
(Bio-Rad Laboratories). mRNA expressions were normalised
using GAPDH.
2.8. Preparation of Membrane Fraction from Skin for Immun-
oblotting [15]. The skin tissue was homogenised in dissect-
ing buﬀer (0.3M sucrose, 25mM imidazole, 1mM EDTA,
8.5μM leupeptin, 1μM PMSF; pH 7.2) using a Physcotron
homogeniser (Microtec Co., Ltd., Chiba, Japan) on ice.
Each homogenate was homogenised using the ultrasonic
homogeniser (UH-50, SMT Co., Ltd, Tokyo, Japan) and then
centrifuged (4,000 × gf o r1 5 m i na t4 ◦C). The resulting
supernatant was centrifuged (200,000×gf o r6 0m i na t4 ◦C).
The supernatant was removed, and dissecting buﬀer was
added to the precipitate. An additional homogenisation step
was then performed using the ultrasonic homogeniser. The
ﬁnal homogenate contained the crude membrane fraction.
2.9. Electrophoresis and Immunoblotting. Protein concentra-
tions were measured by the BCA method [16] using BSA
as a standard. Electrophoresis was performed by Laemmli’s
method [17]. Using the loading buﬀer (84mM Tris, 20%
glycerol, 0.004% bromophenol blue, 4.6% SDS, and 10% 2-
mercaptoethanol; pH 6.3), 6μg of protein was diluted 2-fold
and applied to a polyacrylamide gel. After electrophoresis,
the isolated proteins were transferred to a PVDF membrane.
After blocking for 1h using 1% skim milk, the resulting
membrane was reacted for 1h at room temperature with
rabbit anti-rat AQP3 antibody (1/500). After washing the
membrane with TBS-Tween (20mM Tris-HCl, 137mM
NaCl, and 0.1% Tween 20; pH 7.6), the resulting membrane
was reacted for 1h at room temperature with anti-rabbit
IgG-HRP antibody (1:2,000). After washing the membrane,
the membrane was reacted with the ECL Plus detection
reagent and then visualised with LAS-3000 mini (Fuji Film,
Tokyo, Japan), a luminoimage analyser.
2.10. Immunohistochemistry. Mice were anaesthetised with
ether, and their hearts were perfused with PBS. They were
then perfused with 50mL of ice-cold 4% paraformaldehyde
(PFA) in PBS. The skin was dissected out and post ﬁxed in
4 %P F Ai nP B Sf o r1ha t4 ◦C. Samples were immersed in
30% sucrose/PBS overnight at 4◦C and embedded in OCT
compound (Sakura Finetek USA Inc., Torrance, CA, USA).
Frozensectionswerecutwithacryostat(LeicaMicrosystems,
Tokyo, Japan) at 10μm and mounted onto MAS-coated
glass slides (Matsunami Glass, Osaka, Japan). Sections
were washed with PBS and blocked with blocking solution
(PBS containing 3% FBS and 0.1% Triton X-100) for 1h;
subsequently, sections were incubated overnight at 4◦Ci n
a mixture of rabbit anti-rat AQP3 antibody (1/200) or
mouse anticeramide antibody (1/10). After washing 3 times
with PBS, sections were reacted with secondary antibody
(Alexa Fluor 488 anti-rabbit IgG, 1/200; Alexa Fluor 488
anti-mouse IgM antibody; 1/200) at room temperature for
1h. After washing with PBS, sections were reacted with PI
solution (1/1,000) in PBS at room temperature for 30min,
washed 3 more times with PBS, and then coverslipped with
Vectashield (Vector Laboratories, Burlingame, CA, USA).
Immunostained sections were observed under a microscope
(BZ-9000, Keyence Corporation, Tokyo, Japan).
2.11. Statistical Analysis. Numerical data are expressed as the
mean ± standard deviation. The signiﬁcance of diﬀerences
was evaluated using ANOVA, followed by Tukey’s test. Values
of P<0.05 were considered signiﬁcant.
3. Results
3.1. The Eﬀect of Polyphenol-Rich Aqueous Extract of Acacia
on Spontaneous Itching Behaviour. The frequency of sponta-
neousitchingbehaviourthatoccurred4and6weeksafterthe
PrA administration is shown in Figure 1.
At 4 weeks after the administration, the frequency of
scratching,grooming,andlickingbehaviourintheADgroup
was approximately twice that in the control group. The
frequency of scratching, grooming, and licking in the PrA
1.5% and PrA 3.0% administration groups all decreased
signiﬁcantly compared to that in the AD group and was
nearly equal to that in the control group (Figures 1(a)–1(c)).
The same trends observed 4 weeks after the administration
were also observed 6 weeks after the administration (Figures
1(d)–1(f)).
3.2.TheEﬀectofPolyphenol-RichAqueousExtractofAcaciaon
theDermalWaterContentandtheTransepidermalWaterLoss.
The dermal water content and the transepidermal water loss
at 6 weeks after the administration are shown in Figure 2.
The dermal water content was signiﬁcantly lower in the
AD group than in the control group. The dermal water
content was signiﬁcantly higher in the PrA 1.5% and PrA
3.0% administration groups than in the AD group and was
nearly equal to that in the control group (Figure 2(a)).4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Analysis of spontaneous itching behaviour. HR-1 mice were given free access to a normal diet (control group), HR-AD diet (AD
group), HR-AD diet with 1.5%PrA, or HR-AD diet with 3.0%PrA for 6 weeks. The spontaneous itching behaviour of mice was observed at
4 weeks (a)–(c) and 6 weeks (d)–(f) after the administration, and the frequency of spontaneous itching behaviour per hour was calculated.
Data represent the mean ± SD for 8 mice. Tukey’s test: ∗∗P<0.01 and ∗∗∗P<0.001 versus control group, ##P<0.01 and ###P<0.001
versus AD group.
The transepidermal water loss in the AD group was ap-
proximately 3 times larger than that in the control group.
The transepidermal water loss in the PrA 1.5% and PrA 3.0%
administration groups was signiﬁcantly smaller than that in
the AD group and was nearly equal to that in the control
group (Figure 2(b)).
3.3. The Eﬀect of Polyphenol-Rich Aqueous Extract of Acacia
on Aquaporin-3 (AQP3) Expression in the Skin. The mRNA
expression level and protein expression level of AQP3 in the
skin are shown in Figure 3.
AQP3 expression increases in patients with atopic der-
matitis [18, 19]. The mRNA expression level of AQP3 in the
AD group was approximately 9 times larger than that in the
controlgroup.InthePrA1.5%andPrA3.0%administration
groups, the mRNA expression level of AQP3 showed dose-
dependent decreases (Figure 3(a)).
Two AQP3 protein bands were detected. One of these
appeared at around 27kDa and represented the deglyco-
sylated form of AQP3, and the other appeared at around
30–40kDa and represented a glycosylated form of AQP3
[20, 21]. The glycosylation is associated with the stability
and intracellular translocation of AQP [22, 23] ,b u ti th a sn o
inﬂuence on water permeability [24]. In this study, therefore,
the sum of these bands was analysed as the AQP3 protein
expression level [25, 26]. The AQP3 protein expression level
in the skin in the AD group was approximately 7 times larger
than that in the control group. In the PrA 1.5% and PrA
3.0% administration groups, the AQP3 protein expression
level was less than that in the AD group (Figure 3(b)).
The AQP3 distribution was analysed by immunohis-
tochemical staining (Figure 4). AQP3 was predominantly
expressed in the stratum spinosum and stratum basale in
the control group, in the AD group, and in the PrA 3.0%
administrationgroup.TheAQP3expressionintheADgroupEvidence-Based Complementary and Alternative Medicine 5
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Figure 2: Dermal water content (a) and transepidermal water loss (b). HR-1 mice were given free access to a normal diet (control group),
HR-AD diet (AD group), HR-AD diet with 1.5%PrA, or HR-AD diet with 3.0%PrA for 6 weeks. After 6 weeks, dermal water content (a)
and transepidermal water loss (b) were measured. Data represent the mean ± SD for 8 mice. Tukey’s test: ∗∗∗P<0.001 versus control group,
###P<0.001 versus AD group.
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Figure 3: AQP3 mRNA (a) and protein (b) expression levels in the skin. HR-1 mice were given free access to a normal diet (control group),
HR-AD diet (AD group), HR-AD diet with 1.5%PrA, or HR-AD diet with 3.0%PrA for 6 weeks. (a) The skin was harvested, and the AQP3
mRNA expression level was measured using real-time RT-PCR. GAPDH was used as a housekeeping gene. (b) The skin was harvested, and
theAQP3proteinexpressionlevelwasmeasuredusingWesternblotting.mRNAandproteinexpressionlevelsarepresentedasthepercentage
ofthecontrolgroup(100%).Datarepresentthemean ±SDfor8mice.Tukey’stest: ∗∗∗P<0.001versuscontrolgroup, #P<0.05, ##P<0.01,
and ###P<0.001 versus AD group.
was greater than that in the control group. The AQP3
protein expression level was clearly lower in the PrA 3.0%
administration group than in the AD group.
3.4.TheEﬀectofPolyphenol-RichAqueousExtractofAcaciaon
Ceramide Expression in the Skin. The ceramide distribution
in the skin was analysed by immunohistochemical staining
(Figure 5). In the control group, ceramide was widely
distributed in the stratum corneum [27]. The ceramide
expression level was clearly lower in the AD group than in
the control group. The ceramide expression level in the PrA
3.0% administration group was nearly equal to that in the
control group.
3.5. The Eﬀect of Polyphenol-Rich Aqueous Extract of Acacia
on the Expression of Enzymes That Increase or Decrease the6 Evidence-Based Complementary and Alternative Medicine
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Figure 4: Analysis of the AQP3 expression distribution in the skin. HR-1 mice were given free access to a normal diet (control group),
HR-AD diet (AD group), or HR-AD diet with 3.0%PrA for 6 weeks. After 6 weeks, the skin was harvested and AQP3 (green) and nuclei
(red) were immunostained.
Ceramide Content in the Stratum Corneum. The mRNA ex-
pression levels of serine palmitoyl transferase, which in-
creases the ceramide content in the stratum corneum, are
showninFigure 6(a).NosigniﬁcantdiﬀerencesinthemRNA
expressionlevelswereobservedamongthecontrolgroup,the
AD group, and the PrA group (Figure 6(a)).
The mRNA expression levels of ceramidase, which de-
creases ceramide content in the stratum corneum, are shown
in Figure 6(b). The mRNA expression level of ceramidase in
the AD group was approximately twice that in the control
group. This increase was successfully inhibited by PrA ad-
ministration (Figure 6(b)).
4. Discussion
Atopic dermatitis is a skin disease that is characterised by a
course marked by exacerbations and remissions of pruritic
eczema. The pruritus of atopic dermatitis is a refractory
symptom that generally cannot be controlled with antihis-
tamines. In this study, a mouse model of atopic dermatitis
withpruriticsymptomswaspreparedbygivingmiceaspecial
diet (Table 1) that contained no magnesium according to the
m e t h o dr e p o r t e db yF u j i ie ta l .[ 12, 13]. Spontaneous itching
behaviour was evaluated by observing scratching, grooming,
and licking behaviour. An increase in the spontaneous
itching behaviour was observed in the AD group compared
to the control group; thus, it was conﬁrmed that the itching
associatedwithatopicdermatitiscouldbeproperlyevaluated
in this animal study (Figure 1). In the PrA administration
groups, a decrease in the spontaneous itching behaviour was
observed (Figure 1). These results conﬁrm the inhibitory
eﬀect of PrA on itching associated with atopic dermatitis.
Non allergic factors such as skin dryness are involved
in the development of pruritus associated with atopic
dermatitis. In the AD group, a decrease in the dermal water
content and an increase in the transepidermal water loss
were observed (Figure 2). Therefore, it was suggested that
the pruritus observed in this animal study was caused by
skin dryness. It is considered that PrA may be regulating the
dermal water content because PrA exhibited an inhibitory
eﬀect on the above-mentioned skin dryness (Figure 2).
AQP3 [28]a n dc e r a m i d e[ 29, 30] play important roles
in regulating the dermal water content. A decrease in the
AQP3 expression level in normal skin causes skin dryness, asEvidence-Based Complementary and Alternative Medicine 7
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Figure 5: Analysis of the ceramide expression distribution in the skin. HR-1 mice were given free access to a normal diet (control group),
HR-AD diet (AD group), or HR-AD diet with 3.0%PrA for 6 weeks. After 6 weeks, the skin was harvested and ceramide (green) and nuclei
(red) were immunostained.
AQP3-knockout mice have reduced dermal water content
[28]. In addition, reduced stratum corneum ceramide
content causes an increase in transepidermal water loss,
leading to reduced dermal water content [29, 30]. Therefore,
it is considered that a normal state of ceramide and the
existence of a normal or higher AQP3 level are the essential
conditions for maintaining the normal water content of
the skin. In atopic dermatitis, tumour necrosis factor-α,
which is secreted by keratinocytes, increases the production
of chemokine CCL17, causing an increase in the AQP3
expression level [18, 31]. However, it is also known that a
decrease in the ceramide content in the stratum corneum
associated with atopic dermatitis causes an increase in
transepidermal water loss, leading to a decrease in dermal
water content [29, 30]. In the AD group, the AQP3
expression level was higher than that in the control group
(Figures 3 and 4) and the ceramide expression was lower
than that in the control group (Figure 5). It is considered
that, since the increase in AQP3 expression level in the
AD group takes place under the condition of a decreased
stratum corneum ceramide content, transepidermal water
loss increased, leading to a decreased stratum corneum water
content and an increase in spontaneous itching behaviour.
In the PrA group, it is considered that transepidermal
water loss and the associated spontaneous itching behaviour
were reduced due to a normal level of stratum corneum
ceramide content, although the AQP3 expression level was
slightly increased compared to that in the control group
(Figures 3, 4,a n d5).
In the skin, ceramide is synthesised from palmitoyl
CoA and by serine palmitoyl transferase in the cells of
the stratum basale [32]. The synthesised ceramides move
toward the stratum corneum with skin cell diﬀerentiation
and constructthe lamellarstructureof the stratumcorneum.
At the same time, ceramides in the stratum corneum are
degraded by ceramidase into sphingosine and fatty acids
[33]. Therefore, the stratum corneum ceramide content
reﬂects the balance between the ceramide synthesis by
serine palmitoyl transferase and its degradation by cerami-
dase [34]. In atopic dermatitis model mice, the ceramide
content is decreased due to the increased expression of
ceramidase in the stratum corneum [27]. In the AD
group in this study, the expression level of ceramidase
was increased and the ceramide content in the stratum8 Evidence-Based Complementary and Alternative Medicine
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Figure 6: mRNA expression levels of serine palmitoyl transferase (a) and ceramidase (b) in the skin. HR-1 mice were given free access to a
normal diet (control group), HR-AD diet (AD group), HR-AD diet with 1.5%PrA, or HR-AD diet with 3.0%PrA for 6 weeks. After 6 weeks,
the skin was harvested, and serine palmitoyl transferase (a) and ceramidase (b) mRNA expression levels were measured using real-time
RT-PCR. GAPDH was used as a housekeeping gene. mRNA expression levels are presented as the percentage of the control group (100%).
Data represent the mean ± SD for 8 mice. Tukey’s test: ∗P<0.05 versus control group, #P<0.05 and ##P<0.01 versus AD group.
corneum was reduced (Figures 4 and 6). The stratum
corneum ceramide content in the PrA group was nearly
equal to that in the control group, which may be because
PrA inhibited an increase in the expression of ceramidase
(Figures 4 and 6).
Ithasbeenreportedthatcatechinssuchasteapolyphenol
[9, 10] and apple polyphenol [11]a r ee ﬀective for treating
atopic dermatitis to some extent. It has been revealed
that the mechanism of this eﬀect includes the inhibition
of IgE production [35], the inhibition of the release of
inﬂammatory substances such as histamine from mast cells
[36, 37], and the inhibition of the expression of high aﬃnity
IgE receptor FcεRI in mast cells [38]. Because PrA is also a
polyphenol, it is possible that PrA inhibits the development
of atopic dermatitis by these mechanisms. It is considered
necessary to examine in detail whether PrA inhibits the
development of allergic dermatitis.
In summary, it has been revealed that PrA improves the
itching associated with atopic dermatitis by preventing the
skin from drying. It has also been revealed that PrA prevents
the skin from drying by inhibiting the decrease in ceramide
content in skin aﬀected by atopic dermatitis. Moreover, it
has been revealed that PrA maintains the ceramide content
in the skin because PrA inhibits the increase in ceramidase
expression caused by atopic dermatitis. In the future, PrA is
expected to oﬀer potential as a plant extract that is useful for
alleviating atopic dermatitis.
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